These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6328774)

  • 1. Hepatitis B virus infection. Current concepts of chronicity and immunity.
    Vyas GN; Blum HE
    West J Med; 1984 May; 140(5):754-62. PubMed ID: 6328774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiology of hepatitis B virus.
    Gerber MA; Thung SN
    Pathobiol Annu; 1981; 11():197-228. PubMed ID: 6276845
    [No Abstract]   [Full Text] [Related]  

  • 4. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
    Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
    Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis DNA viruses and their correlation to hepatocellular cancer].
    Roggendorf M
    Internist (Berl); 1985 Oct; 26(10):621-7. PubMed ID: 3000972
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
    Rosina F; Saracco G; Rizzetto M
    N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of carriers of hepatitis B virus from a tertiary referral hospital: does the viral load change during the natural course of infection?
    Aakanksha ; Asim M; Sharma PK; Das BC; Kar P
    J Med Virol; 2011 Jul; 83(7):1151-8. PubMed ID: 21520137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
    Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular biology of hepatitis B virus.
    Shafritz DA; Lieberman HM
    Annu Rev Med; 1984; 35():219-32. PubMed ID: 6326660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B and the delta agent].
    Jilg W; Roggendorf M; Zoulek G; Schlipköter U; Deinhardt F
    Fortschr Med; 1984 Feb; 102(6):119-21. PubMed ID: 6706267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.